NASDAQ
13.03USD
+0.32 (+2.53%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
448.7M
P/E
—
EPS
—
Beta
0.26
52W range
9.85-16.76
Day range
12.76–13.35
Open
12.79
Prev close
12.71
Volume
193K
Avg volume
126.2K
Dividend
0.77
IPO
2014-06-24
https://www.globenewswire.com/news-release/2026/01/11/3216469/0/en/Benitec-Biopharma-Provides-Positive-Long-Term-Clinical-Study-Results-for-BB-301-Phase-1b-2a-Clinical-Trial-Demonstrating-Robust-Efficacy-and-Continued-Durability-of-Response.html · 1/11/2026+1.00
https://www.zacks.com/stock/news/2808653/does-benitec-biopharma-bntc-have-the-potential-to-rally-83-87-as-wall-street-analysts-expect?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|consensus_price_target-2808653 · 12/24/2025+0.80
https://www.globenewswire.com/news-release/2025/11/05/3182031/0/en/Benitec-Biopharma-Inc-Announces-Proposed-Public-Offering.html · 11/5/2025-0.20
https://www.globenewswire.com/news-release/2025/11/03/3179118/0/en/Benitec-Biopharma-Provides-Positive-Interim-Clinical-Study-Results-for-BB-301-Phase-1b-2a-Clinical-Trial-and-Receives-FDA-Fast-Track-Designation-for-BB-301.html · 11/3/2025
https://www.defenseworld.net/2025/10/26/benitec-biopharma-limited-nasdaqbntc-given-consensus-rating-of-moderate-buy-by-analysts.html · 10/26/2025+0.60
Benitec Biopharma Inc. is an emerging biotechnology firm dedicated to advancing groundbreaking genetic medicines. The company specializes in DNA-directed RNA interference (RNAi) based treatments, which it develops to address severe and enduring human conditions. Its pipeline features BB-301, an adeno-associated virus (AAV) gene therapy aimed at treating oculopharyngeal muscular dystrophy, and BB-103, designed to combat chronic hepatitis B virus infection. Established in 1995, Benitec Biopharma's main operations are situated in Hayward, California.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
